Similar articles

• Maternal hypertension, antihypertensive medication use, and the risk of severe hypospadias.

  Caton AR, Bell EM, Druschel CM, Werler MM, Mitchell AA, Browne ML, McNutt LA, Romitti PA, Olney RS, Correa A; National Birth Defects Prevention Study. Caton AR, et al. Birth Defects Res A Clin Mol Teratol. 2008 Jan;82(1):34-40. doi: 10.1002/bdra.20415. Birth Defects Res A Clin Mol Teratol. 2008. PMID: 18022875
• Maternal hypertension, medication use, and hypospadias in the National Birth Defects Prevention Study.

  Van Zutphen AR, Werler MM, Browne MM, Romitti PA, Bell EM, McNutt LA, Druschel CM, Mitchell AA; National Birth Defects Prevention Study. Van Zutphen AR, et al. Obstet Gynecol. 2014 Feb;123(2 Pt 1):309-317. doi: 10.1097/AOG.0000000000000103. Obstet Gynecol. 2014. PMID: 24402588 Free PMC article.
• [Hypertension in pregnancy. ACE inhibitors and angiotensin II receptor antagonists are contraindicated because of their potential fetotoxicity].

  Partosch F, Stahlmann R. Partosch F, et al. Med Monatsschr Pharm. 2011 Oct;34(10):358-62. Med Monatsschr Pharm. 2011. PMID: 22010419 Review. German. No abstract available.
• Maternal hypertensive disorders, antihypertensive medication use, and the risk of birth defects: a case-control study.

  van Gelder MM, Van Bennekom CM, Louik C, Werler MM, Roeleveld N, Mitchell AA. van Gelder MM, et al. BJOG. 2015 Jun;122(7):1002-9. doi: 10.1111/1471-0528.13138. Epub 2014 Nov 14. BJOG. 2015. PMID: 25395267
• [Treatment of hypertension in pregnancy--verified, questionable and controversial treatment].

  Wunderlich M, Finn H. Wunderlich M, et al. Z Arztl Fortbild (Jena). 1990;84(4):143-6. Z Arztl Fortbild (Jena). 1990. PMID: 2186573 Review. German. No abstract available.